| A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer (NCT00040092) | Aptose Biosciences Inc. | 2002-07-01 |
| Pancreatic Cancer Genetic Epidemiology (PACGENE) Study (NCT00526578) | M.D. Anderson Cancer Center | 2002-06-19 |
| The Significance of Postoperative Muscle Wasting in Pancreatic Cancer (NCT06093009) | National Cheng-Kung University Hospital | 2002-06-01 |
| Prospective Study of Celiac Block Injection: 1 vs. 2 (NCT00583479) | Indiana University | 2002-06-01 |
| Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients (NCT00899626) | Vanderbilt University Medical Center | 2002-06-01 |
| A Prospective Study of EUS Guided Celiac Block (NCT00583271) | Indiana University | 2002-06-01 |
| Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer (NCT00238199) | OHSU Knight Cancer Institute | 2002-06-01 |
| Chemotherapy and Radiation Following Pancreatic Surgery (NCT00660270) | Washington University School of Medicine | 2002-05-01 |
| Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer (NCT00068575) | M.D. Anderson Cancer Center | 2002-05-01 |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (NCT00310115) | M.D. Anderson Cancer Center | 2002-04-01 |
| Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT00032175) | Cancer Research UK | 2002-04-01 |
| Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer (NCT00813696) | Istituti Tumori Giovanni Paolo II | 2002-04-01 |
| Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer (NCT00202800) | Corewell Health West | 2002-03-01 |
| Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer (NCT00040833) | Memorial Sloan Kettering Cancer Center | 2002-02-01 |
| CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer (NCT00033384) | University of Alabama at Birmingham | 2002-02-01 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer (NCT00027534) | Michael Morse, MD | 2002-01-01 |
| Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas (NCT00084383) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2002-01-01 |
| Parenteral Nutrition Support for Patients With Pancreatic Cancer (NCT00919659) | CONKO-Studiengruppe | 2002-01-01 |
| Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer (NCT00176735) | University of Michigan Rogel Cancer Center | 2001-12-01 |
| OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. (NCT00040183) | OSI Pharmaceuticals | 2001-11-29 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer (NCT00025168) | Wake Forest University Health Sciences | 2001-11-01 |
| Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer (NCT00026338) | NCIC Clinical Trials Group | 2001-10-29 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer (NCT00026403) | Alliance for Clinical Trials in Oncology | 2001-09-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer (NCT00026130) | Alliance for Clinical Trials in Oncology | 2001-09-01 |
| Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy (NCT01059097) | Università Vita-Salute San Raffaele | 2001-08-01 |
| Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors (NCT00033241) | OSI Pharmaceuticals | 2001-07-23 |
| BMS-247550 in Treating Patients With Advanced Pancreatic Cancer (NCT00016965) | SWOG Cancer Research Network | 2001-07-01 |
| Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer (NCT00058201) | Royal Liverpool University Hospital | 2001-07-01 |
| Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT00023972) | Daiichi Sankyo | 2001-07-01 |
| DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer (NCT00024375) | Theradex | 2001-06-01 |
| Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer (NCT00030732) | Swiss Cancer Institute | 2001-06-01 |
| The Impact of Immunostimulating Nutrition on the Outcome of Surgery (NCT00558155) | Jagiellonian University | 2001-06-01 |
| Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas (NCT00079365) | University of South Florida | 2001-05-01 |
| BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery (NCT00024362) | Theradex | 2001-05-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer (NCT00025532) | University of California, San Francisco | 2001-04-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer (NCT00010270) | University Hospital Freiburg | 2001-04-01 |
| Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer (NCT02118077) | Cancer Advances Inc. | 2001-04-01 |
| Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection (NCT00014651) | Mayo Clinic | 2001-03-01 |
| Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer (NCT00024427) | Wellstat Therapeutics | 2001-02-01 |
| Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas (NCT00006467) | Alliance for Clinical Trials in Oncology | 2001-02-01 |
| Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma (NCT00044031) | Cancer Advances Inc. | 2001-02-01 |
| Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas (NCT00012220) | Alliance for Clinical Trials in Oncology | 2001-01-01 |
| Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas (NCT00010166) | Wake Forest University Health Sciences | 2000-12-01 |
| Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers (NCT00183846) | University of Southern California | 2000-12-01 |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer (NCT00006981) | National Cancer Institute (NCI) | 2000-12-01 |
| Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer (NCT00027521) | Ichor Medical Systems Incorporated | 2000-12-01 |
| Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer (NCT00006387) | Fox Chase Cancer Center | 2000-10-01 |
| Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer (NCT00010062) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2000-10-01 |
| Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders (NCT00830557) | Mayo Clinic | 2000-10-01 |
| An Open Label Study to Evaluate G17DT Compared to Gemcitabine (NCT03200821) | Cancer Advances Inc. | 2000-08-14 |
| ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas (NCT00005594) | University of Alabama at Birmingham | 2000-07-01 |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer (NCT00900094) | University of Michigan Rogel Cancer Center | 2000-06-01 |
| Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas (NCT00005926) | National Cancer Institute (NCI) | 2000-06-01 |
| S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT00005832) | SWOG Cancer Research Network | 2000-06-01 |
| R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer (NCT00005843) | National Cancer Institute (NCI) | 2000-05-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer (NCT00005858) | University of Maryland, Baltimore | 2000-04-01 |
| Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery (NCT00003798) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-04-01 |
| Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer (NCT00004879) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery (NCT00416507) | Federation Francophone de Cancerologie Digestive | 2000-03-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract (NCT00582647) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer (NCT00033735) | Eisai Inc. | 2000-01-01 |
| Reoperation After Pancreaticoduodenectomy (NCT04387903) | Mansoura University | 2000-01-01 |
| Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction (NCT00004910) | Northwestern University | 2000-01-01 |
| Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer (NCT00005053) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-12-01 |
| Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas (NCT00005591) | University of Alabama at Birmingham | 1999-10-01 |
| Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer (NCT00004190) | Alliance for Clinical Trials in Oncology | 1999-10-01 |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery (NCT00004895) | Northwestern University | 1999-10-01 |
| Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer (NCT00004861) | Pfizer | 1999-10-01 |
| Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT00006117) | GERCOR - Multidisciplinary Oncology Cooperative Group | 1999-09-01 |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas (NCT00003810) | Eastern Cooperative Oncology Group | 1999-08-11 |
| Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer. (NCT02098239) | Cancer Advances Inc. | 1999-08-01 |
| Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00004095) | Northwestern University | 1999-08-01 |
| Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer (NCT00004884) | European Organisation for Research and Treatment of Cancer - EORTC | 1999-07-01 |
| DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas (NCT00003951) | Daiichi Sankyo | 1999-06-01 |
| An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma (NCT02098291) | Cancer Advances Inc. | 1999-04-01 |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery (NCT00004003) | Barbara Ann Karmanos Cancer Institute | 1999-04-01 |
| Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer (NCT00003851) | Columbia University | 1999-03-01 |
| Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas (NCT00003797) | Brown University | 1999-03-01 |
| Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas (NCT00005870) | Astex Pharmaceuticals, Inc. | 1999-03-01 |
| Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas (NCT00003923) | Memorial Sloan Kettering Cancer Center | 1999-03-01 |
| Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder (NCT00489515) | Wake Forest University Health Sciences | 1999-02-01 |
| Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer (NCT00003769) | Indiana University | 1999-02-01 |
| Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer (NCT00003677) | M.D. Anderson Cancer Center | 1999-02-01 |
| Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct (NCT00010088) | GERCOR - Multidisciplinary Oncology Cooperative Group | 1999-01-01 |
| Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas (NCT00003780) | Meyer Pharmaceuticals | 1998-12-01 |
| Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer (NCT00005871) | Astex Pharmaceuticals, Inc. | 1998-11-01 |
| Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer (NCT00003760) | The University of Texas Health Science Center at San Antonio | 1998-11-01 |
| Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer (NCT00003411) | University of Pittsburgh | 1998-11-01 |
| Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer (NCT00003591) | Radiation Therapy Oncology Group | 1998-11-01 |
| Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer (NCT00005869) | Astex Pharmaceuticals, Inc. | 1998-11-01 |
| Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer (NCT00003546) | Alliance for Clinical Trials in Oncology | 1998-09-01 |
| Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas (NCT00019513) | National Institutes of Health Clinical Center (CC) | 1998-08-01 |
| Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas (NCT00003216) | Radiation Therapy Oncology Group | 1998-07-01 |
| Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer (NCT00003434) | Duke University | 1998-06-01 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors (NCT00019435) | National Cancer Institute (NCI) | 1998-05-01 |
| Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer (NCT00008099) | University of Pittsburgh | 1998-05-01 |
| Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer (NCT00003426) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer (NCT00003427) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer (NCT00019474) | Montefiore Medical Center | 1998-03-01 |